CURRICULUM VITAE
Charleston, SC 29407
Tel: 843-***-****
Email: ********@*****.***
Quan Fang, M.D./Ph.D.
li
Education
1. 1995-2001 Ph.D. Fudan University Medical School (former
Shanghai Medical University), Shanghai, China, 2001
2. 1988-1993 M.D. Tongji Medical University, Wuhan, China, 1993
Research Experience
. 2011- current
Volunteer researcher, Medical University of South Carolina
. 2006 - 2010
Postdoctoral Fellow, Medical University of South Carolina,
Charleston, South Carolina
. 2002 -March 2006
Postdoctoral Fellow, University of South Florida, Tampa, Florida
. 2001 - September 2002
Postdoctoral Fellow, University of Pittsburgh Cancer Institute
Research Background:
Cell biology and molecular cell biology:
1. Primary cell culture & cell line generating, mouse MEF cell line
generating, cell transfection, cell cloning and in vitro cell
function assay. Virus transduction, siRNA/shRNA generation.
2. Gene cloning and subcloning, gene expression, protein expression,
protein-protein interaction analysis, protein modification
analysis.
3. Western blot and IP, CHIP assay, RT-PCR, real-time PCR, Northern
blot.
4. Monoclonal antibody and fusion protein construction, and
purification by chromatography.
Immunological techniques:
Mouse PBMC and spleen cells isolation and cell surface marker staining
CD3, CD4, CD8, NK, CD56.
T cell function assay (cytotoxic T lymphocyte assay, BD Cytokine Bead
assay, ELISPOT assay, ELISA, Bio-Rad multiplex cytokines assay).
Complement related assay (complement activation, IgG binding assay).
Intracellular staining measured by flow cytometry or fluoroscopy.
Single chain antibody (scfv) generating and clone selection. Fusion
scfv antibodies purification.
Animal experiments:
Mouse subcutaneous tumor model, animal chemotherapy, localized tumor
radiotherapy, knockout mice clone selection and maintaining.
Publications
1. Fang Q, Tomlinson S., Enhancing antitumor radiotherapy by targeting
apoptotic cell clearance. Manuscript is in preparation.
2. Neumann CA, Fang Q, Are peroxiredoxins tumor suppressors. Curr Opin
Pharmacol. 2007 Aug;7(4):375-80
3. Naidu, K.A., Fang Q., Cheng, J-Q., Nicosia V N., Coppola, D. p53
Enhances Ascorbyl Stearate Induced G2-M Arrest of Human Ovarian
Cancer Cells. Anticancer Res. 2007 Nov-Dec;27(6B):3927-34. (co-
first author)
4. Fang Q. Naidu, K. A., Naidu K. A., Sun M., Dan H C., Nicosia V N.,
Cheng, J-Q., Coppola D. Ascorbyl Stearate Inhibits Cell
Proliferation and Survival in Human Ovarian Carcinoma Cells by
Targeting PI3K/AKT2 Pathway. Anticancer Research 2006, Feb;
26(1A):203-9
5. Hu B., Guo P., Fang Q., Tao, H.-Q., Schafer, A. C., Wang, D.-G., Su
Huang, H.-J., Gunji, Y., Nagane, M., Nishikawa, R., Alitalo, K.,
Cavenee, W. K., and Cheng, S.-Y. Angiopoietin-2 Induces Human
Glioma Invasion through the Activation of Metalloprotease-2. Proc.
Natl. Acad. Sci. USA, 100: 8904-8909, 2003. (co-first author)
6. Guo P., Fang Q., Tao H.-Q., Schafer A C., FentonB. M., Ding I., Hu
B., and Cheng,
S.-Y. Overexpression of Vascular Endothelial Growth Factor
Isoforms, VEGF121 and VEGF165, Enhances Estrogen-dependent and
Estrogen-independent Human MCF-7 Breast Tumor Growth. Cancer Res.,
63: 4684-4691, 2003.
7. Hakam A., Fang Q., Karl R., and Coppola D. Coexpression of IGF-1R
and c-Src proteins in human pancreatic ductal adenocarcinoma. Dig.
Dis. Sci., 48: 1972-1978, 2003.
8. Sekharam M., Zhao H., Sun M., Fang Q., Zhang Q., Yuan Z., Dan H.C.,
Boulware D., Cheng J.Q., and Coppola D. Insulin-like growth factor
1 receptor enhances invasion and induces resistance to apoptosis of
colon cancer cells through the Akt/Bcl-x(L) pathway. Cancer Res.,
63:7708-7716, 2003.
References:
1. Stephen Tomlinson Ph.D Professor
Department of Microbiology and Immunology,
Medical University of South Carolina
173 Ashley Avenue, Room CRI 213
Charleston, SC 29425
phone: 843-***-****
Email: ********@****.***
2. Azizul Haque, Ph.D, Associate Professor
Department of Microbiology and Immunology
Medical University of South Carolina
173 Ashley Avenue, Room CRI 206
Charleston, SC 29425
Phone: 843-***-****
Email: *****@****.***
3. Santo Nicosia, M.D. Professor, Chairman
Department of Pathology, University of South Florida
12901 Bruce B. Downs, MDC Box 11
Tampa, FL 33612
Phone: 813-***-****
email: ********@***.***.***
Research interest
Specialty: breast cancer, ovarian cancer, glioma cancer, angiogenesis,
apoptosis, cell signaling, tumor metastasis, cancer immunology